Teeranan AngkananardThunyarat AnothaisintaweeMark McEvoyJohn AttiaAmmarin ThakkinstianUniversity of Newcastle, Faculty of Health and MedicineFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversitySrinakharinwirot University2019-08-232019-08-232018-01-01BioMed Research International. Vol.2018, (2018)23146141231461332-s2.0-85057390706https://repository.li.mahidol.ac.th/handle/20.500.14594/45325© 2018 Teeranan Angkananard et al. Objective. This systematic review aimed to measure the association between neutrophil lymphocyte ratio (NLR) and cardiovascular disease (CVD) risk. Methods. Relevant studies were identified from Medline and Scopus databases. Observational studies with NLR as a study factor were eligible for review. The outcomes of interest were any type of CVD including acute coronary syndrome, coronary artery disease, stroke, or a composite of these cardiovascular events. Mean differences in NLR between CVD and non-CVD patients were pooled using unstandardized mean difference (USMD). Odds ratios of CVD between high and low NLR groups were pooled using a random effects model. Results. Thirty-eight studies (n=76,002) were included. High NLR was significantly associated with the risks of CAD, ACS, stroke, and composite cardiovascular events with pooled ORs of 1.62 (95% CI: 1.38-1.91), 1.64 (95% CI: 1.30, 2.05), 2.36 (95% CI: 1.44, 2.89), and 3.86 (95% CI: 1.73, 8.64), respectively. In addition, mean NLRs in CAD, ACS, and stroke patients were significantly higher than in control groups. Conclusion. High NLR was associated with CAD, ACS, stroke, and composite cardiovascular events. Therefore, NLR may be a useful CVD biomarker.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyReviewSCOPUS10.1155/2018/2703518